CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD.
Govoni M, Bassi M, Girardello L, Lucci G, Rony F, Charretier R, Galkin D, Faietti ML, Pioselli B, Modafferi G, Benfeitas R, Bonatti M, Miglietta D, Clark J, Pedersen F, Kirsten AM, Beeh KM, Kornmann O, Korn S, Ludwig-Sengpiel A, Watz H.
Govoni M, et al. Among authors: beeh km.
Respir Res. 2024 Oct 19;25(1):380. doi: 10.1186/s12931-024-02999-5.
Respir Res. 2024.
PMID: 39427187
Free PMC article.
Clinical Trial.